Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials
LEXINGTON, Mass., Feb. 20, 2024 -- Fractyl Health, Inc. , a metabolic therapeutics company focused on pioneering new approaches for the treatment of Type 2 Diabetes and obesity, today announced...
Source: marketscreener.com